What is the Market's View on Qiagen NV (QGEN) Stock's Price and Volume Trends Wednesday?

Overall market sentiment has been high on Qiagen NV (QGEN) stock lately. QGEN receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Qiagen NV has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on QGEN!

See Full QGEN Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With QGEN Stock Today?

Qiagen NV (QGEN) stock has risen 0.09% while the S&P 500 has fallen -0.43% as of 1:16 PM on Wednesday, Oct 5. QGEN has risen $0.04 from the previous closing price of $43.76 on volume of 345,222 shares. Over the past year the S&P 500 has fallen -12.23% while QGEN has fallen -13.47%. QGEN earned $2.23 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 19.68.

More About Qiagen NV

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%). Click Here to get the full Stock Report for Qiagen NV stock.